Corporate
Corcept Crashes 50% After FDA Rejects Relacorilant for Cushing's Syndrome
Jan 1
You're signed outSign in or to get full access.
Leadership at CORCEPT THERAPEUTICS
Browse executives, board members, and key leadership.
Executives at CORCEPT THERAPEUTICS
Joseph K. Belanoff, M.D.
Chief Executive Officer and President
CEO
Executive
Board
Atabak Mokari
Chief Financial Officer and Treasurer
Executive
Charles Robb
Chief Business Officer and Secretary
Executive
Hazel Hunt, Ph.D.
Chief Scientific Officer
Executive
Joseph D. Lyon
Chief Accounting and Technology Officer
Executive
Sean Maduck
President, Corcept Endocrinology
Executive
William Guyer, Pharm.D.
Chief Development Officer
Executive